Please join us for an Industry Theater BUILDING ON FOUNDATIONAL PATHWAYS: A New Treatment Option for PAH Tuesday, May 21, 2024 11:45 am - 12:30 pm PT Innovation Theater 4 The ATS 2024 Exhibit Hall The San Diego Convention Center This industry theater will feature Richard Channick, MD, a PAH thought leader, who will review a new treatment option for patients with pulmonary arterial hypertension (PAH). Faculty: Richard Channick, MD Saul Brandman Chair in Pulmonary Arterial Hypertension Professor of Medicine Pulmonary and Critical Care Division David Geffen School of Medicine at University of California, Los Angeles Los Angeles, California This consultant is a paid speaker for Johnson & Johnson. © Actelion Pharmaceuticals US, Inc. 2024 04/24 cp-442519v1 This promotional educational activity is brought to you by Johnson & Johnson and is not certified for CME. The consultant is a paid speaker for Johnson & Johnson. The speaker is presenting on behalf of Johnson & Johnson and must present information in compliance with FDA requirements applicable to Johnson & Johnson. An Industry Program presentation at the ATS 2024 International Conference. This presentation is sponsored by Johnson & Johnson and is open to all ATS 2024 International Conference attendees.